Neurology (1999) 53(9):193742
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
For a soft comfort meal, see creamy chicken rice soup
they do not establish any therapeutic benefit for any condition, and critically they are not studies of the no-DAC form used in blends
Its the active ingredient in Zepbound (weight loss) and Mounjaro (Type 2 diabetes)
PI3K, phosphatidylinositol-3-kinase
